Curriculum Vitae
Kenneth S. Koeneman, MD

Urologic Oncology  Research Fellow
University of Virginia, Charlottesville, VA
July 1998- June 30, 2000

Resident, Urology
Loyola University Medical Center, Maywood, IL
July 1994-June 1998

Resident, General Surgery
Loyola University Medical Center, Maywood, IL
July 1992-June 1994

M.D.
University of Illinois at Chicago
August 1988-May 1992

Top of page

ACADEMIC POSITIONS:

Associate Professor, Full tenure,
Department of Urologic Surgery, University of Minnesota,
Director, Center for Prostate Cancer
Dougherty Family Chair in Uro-Oncology 
May 2004-present

Assistant Professor, Urologic Oncology
Department of Urology, University of Texas
Southwestern Medical School, Dallas, TX
July 1, 2000 to April 30, 2004

Clinical Assistant Professor, Department of Urology
Univ. of Virginia, Charlottesville, VA
July 1, 1999 to June 30,2000

Top of page

LICENSURE:

State of Minnesota, March 2004 to present
State of Texas, May 2000 to present
State of Virginia, January 1999 to July 2000
State of Illinois, July 1992 to July 1999

Top of page

CERTIFICATION:

American Board of Urology:  Feb. 2002 - Feb. 2012

Top of page

PEER REVIEW ACTIVITY:

Editor, Section of Laboratory Research, for Urologic Oncology

Reviewer of manuscripts for: Urology, Journal of Urology, Journal of Surgical Oncology, and Urologic Oncology: Seminars and Original Investigations. 

“Ad hoc” reviewer for: Molecular Therapy, JNCI, Clinical Cancer Research, Oncogene, and The Prostate.

Top of page

PROFESSIONAL ASSOCIATIONS:

Member, American Urological Association (AUA) and North Central Section
Member, American Society of Gene Therapy (ASGT)
Member, American Assoc. of Cancer Research (AACR)
Member, Society of Urologic Oncology (SUO)

Top of page

AWARDS & GRANTS:

D.O.D. PCRP-02 Consortium Grant:  “Synergy Consortium Targeting New Therapeutics of Lethal Phenotypes of Prostate  Cancer”, Consortium Director:  Jonathan W. Simons, Emory University, May  2003 – January 2006

D.O.D., CDMRP, Young Investigator Award: “Treating CaP Bone Mets with Systemic Antitelomerase Therapy”, March 2002-2005.

D.O.D., CDMRP, Young Investigator Award: “A Novel, Tumor-Specific Gene Therapy in CaP Bone Mets”, June 2001-May 2004

Pfizer Scholar in Urology Award, 2000, University of Virginia

CaP Cure Foundation Research Award: Tumor Specific Promoter Gene Therapy for Prostate Cancer Metastasis; Co-investigator January 1999.

NIH Funded Training T-32 Grant: Program in Cell and Molecular Biology of the Urogenital System. University of Virginia, July 1998-June 2000.

American Foundation For Urologic Disease (AFUD) Research Scholar, 1998-2000, “Novel Therapy for Prevention of Prostate Cancer Dissemination and Treatment of Prostate Cancer  Metastasis”

Pfizer Scholar in Urology Award, 1997, Loyola University Medical Center
1st Place Winner, Charles B. Huggins Essay Contest of Chicago Urological

Society, Basic Science Division, January 1998: Telomerase Activity and DNA Ploidy in PIN

Winner, Chicago Urology Resident Debate, May 1997: Neoadjuvant Hormonal Therapy prior to Prostatectomy

Cardinal Spellman Award for Class of 1988: For distinguished scholarship, and exemplification of ideals of the University (of Dallas)

Top of page

COMMITTEES:

Hereditary Cancer Group Member, U of MN Comprehensive Cancer Center
TPF Advisory Board Member, U of MN Comprehensive Cancer Center
Cancer Progression and Metastasis Group Member, U of MN Comprehensive Cancer Center
AUA NCS Editorial and Awards Committee, 09/08/06
AUA Program Planning Committee for 2006 Annual Meeting, 2005-2006
SUO Annual Meeting Chair, Spring 2005
Member NCI Comprehensive Cancer Center, University of Minnesota, 2004-present
Member, UTSW Cancer Committee, Zale University Hospital and Parkland County Hospital, 2000-2004
Member, UTSW Medical Student Interviewer/Admission Committee, 2000-2004

Top of page

SURGICAL COURSES:

“Endourology & Urologic Laparoscopy”, October 9-10, 2006, University of Minnesota.

“Endourology & Urologic Laparoscopy”, Course Instructor, April 21-23, 2005, University of Minnesota.  Video Conference, Didactic: Robotic Laparoscopic Radical Prostatectomy Lectures: 1. Instrumentation & Technique—Robotic Prostate, Moderator: 1. Case Management—Prostate Cancer

“Advanced Techniques in Laparoscopic Urologic Surgery”, Course Director, September 17, 2004, University of Minnesota Center for Minimally Invasive Surgery.  Lectures: 1. Hand Assisted Laparoscopic Nephrectomy, 2. Review of Literature, 3. Techniques for >10 cm Renal Mass, 4. Hand Assisted Laparoscopic Cystectomy, 5. Introduction to Laparoscopic Radical Prostatectomy.

“Hand-Assisted Laparoscopy”, Course Instructor, March 22-23, 2002, UTSW Center for Minimally Invasive Surgery.

“Hand-assisted Laparoscopic Management of Renal Tumors and GU Malignancies”, Course Director, 09/06/02, UTSW Center for Minimally Invasive Surgery.

Top of page

GRANTS:

Active

Department of Defense, C.D.M.R.P. Program, Young Investigator Award, 2001-2003, “A Novel Tumor-Specific Gene Therapy for Advanced Osseous Prostate Cancer”, Grant # DAMD 17-01-1-0107, June 2001 to June 2004.

D.O.D., CDMRP, Young Investigator Award: “Treating CaP Bone Mets with Systemic Antitelomerase Therapy”, Grant # DAMD 17-02-1-0148, January, 2002 to December, 2006.

D.O.D. PCRP-02 Consortium Grant:  “Synergy Consortium Targeting New Therapeutics of Lethal Phenotypes of Prostate Cancer”, Consortium Director:  Jonathan W. Simons, Emory University, February 2002 to March 2007.

Inactive

Koeneman, K.S., Taylor, R.P., Chung, L.W.K : “ Novel Therapy  for Prevention of  Prostate Cancer Dissemination and Treatment  of  Prostate  Cancer Metastasis", accepted American Foundation for  Urologic Disease, Research Scholar Program 1998-2000, Department of Urology, University of Virginia, Charlottesville, VA.

NIH Funded Training Grant:  Program in Cell and Molecular Biology of the Urogenital System, 5-T32-dK07642, July 1998 to June 2000.

CaP Cure Foundation Research Award; “Gene Therapy Strategy to Enhance the Targeting of Prostate Cancer Bone Metastasis Using Controlled Tumor-Specific Promoters”, Co-investigator (PI- Chung, L.W.K.), January 1999 to January 2000.

CaP Cure Foundation Research Award; “Targeting prostate cancer skeletal metastasis through the community effect”, Co-investigator (PI- Chung, L.W.K.), January 2000 to January 2001.

Clinical Trial Experience: subinvestigator in FDA approved, IND protocol. Loyola University Medical Center, Novartis Protocol 032: A double-Blind, Multi-centered, Randomized Safety and Efficacy trial of Intravenous Aredia™ (90 mg) versus Placebo for the Palliation of Bone Pain in the Patient with Advanced Prostate Cancer; PI: Robert C. Flanigan, M.D., 1998 to 1999. 

University of Virginia Health Sciences Center, Adenovirus Vector(Ad-OC-TK, BioReliance) Expressing Thymidine Kinase Gene Under Regulation of Osteocalcin Promoter and Valacyclovir(BB-IND #8115); PI Thomas A. Gardner, M.D., 1999 to 2000.

University of Texas Southwestern Medical Center: Oral ABT-627 (atresentam) for Prostate Cancer Bone Metastasis, Co-investigator, 2001 to 2002. (Abbott Pharmmaceuticals)

University of Texas Southwestern Medical Center:  Oral R-Fluribuprophen for Relapsed Prostate Cancer, Site P.I., 2002 to 2005. (Myriad Pharmaceuticals)

University of Minnesota: Dendreon Immunotherapy Trial for Prostate Cancer, 2005.

University of Minnesota: Sanofi-Aventis CaP Registry Trial, 2005.

Top of page

PATENTS:

"Bone sialoprotein (BSP)promoter-based toxic gene threrapy for the treatment of calcified tumors and tissues", December 1999 with L.W.K. Chung , et al.

“Osteonectin Based Toxic Therapy for the Treatment of Calcified Tumors and Tissue”, May 2000 with L.W.K. Chung, et al.

Top of page

ARTICLES:

1. Koeneman, K.S., Mulhall, J.P., Goldstein, I.:  Sexual Health for the Man at Midlife: in-office workup. Geriatrics, 52(9) : 76-78, 84-86,  September, 1997.

2. Koeneman, K.S., Pan, C., Jin, J., Pyle, J.M., Flanigan, R.C., Shankey, T.V., Diaz, M.O.:  Telomerase Activity, Telomere Length, and DNA Ploidy in Prostatic Intraepithelial Neoplasia (PIN).  J. of Urology, 160, 1533-1539, October 1998.

3. Pan, X-P. Koeneman, K.S.: A Novel Tumor Specific Gene Therapy for Bladder Cancer. Medical Hypothesis, 53 (2), 130-135, Aug. 1999.

4. Koeneman, K.S., Yeung, F., Chung, L.W.K.:  Osteomimetic Properties of Prostate Cancer Cells:  A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment.  The Prostate 39:246-261, June 1999.

5. Koeneman KS, Kao C, Ko S-C, Yang L, Wada Y, Kallmes DA, Gillenwater JY, Zhau HYE, Chung LWK, Gardner TA.  Osteocalcin Directed Gene Therapy for Prostate Cancer Bone Metastasis.  World J. Urol, 18(2):102-10, April, 2000.

6. Cinar B, Koeneman KS, Edlung M. Prins GS, Zhan EH, Chung LWK.  Androgen Receptor Mediated Reduced Tumor Growth, Enhanced Androgen Responsiveness, and Selected Target Gene Activation in Human Prostate Cancer, Cancer Research, 61, 7310-7317, Oct. 1, 2001.

7. Koeneman, KS, Baseman AG.  Gene Therapy for Advanced Prostate Cancer:  The future is now.  Dallas Medical Journal, 87 (6), 246-248, June 2001.

8. Koeneman, K.S., Hsieh, JT: Gene Therapy in Prostate Cancer, Current Opinion in Urology, 11, 489-494, October, 2001.

9. Ogan K., Lotan Y., Koeneman K, Pearle M., Cadeddu J.  Laparoscopic Versus Open Retroperitoneal Lymph Node Dissection:  A Cost Analysis.  J of Urol., 168,1945-1949, November 2002.

10. Duchene D.A., Lotan Y., Cadeddu J.A., Sagalowsky A.I., Koeneman K.S.: Histopathology of Surgically Managed Renal Tumors:  Analysis of a Contemporary Series.  Urology, 62: 827-30, 2003.

11. Ogan K., Jacomides L., Saboorian H., Koeneman K., Li Y, Napper C., Hoopman J, Pearle M.S., Cadeddu J. A.:  Sutureless laparoscopic heminephrectomy using laser tissue soldering.  J. Endourol.2003 Jun: 17(5):295-300.

12. Lotan Y., Duchene D.A., Cadeddu J.A., Koeneman K.S.:  Cost Comparison for Hand-Assisted Laparoscopic nephrectomy and Open Nephrectomy:  Analysis of Individual Parameters.  J. of Urology, 170: 752-5, 2003

13. Lotan Y., Duchene D.A., Cadeddu J.A., Sagalowsky A.I., Koeneman K.S.  Changing Management of Organ Confined Renal Masses.  Journal of Endourology, Vol. 18 (3), April, 2004.

14. Sherwood J.B., Gettman M.T., Cadeddu J.A., Koeneman K.S.:  Laparoscopic Retroperitoneal Lymph Node Dissection in the Extremely Obese Patient:  Technical Insight Into Access, Port Number, and Port Placement. Journal of the Society of Laparoendoscopic Surgeons (JLSL) 7 (3): 265-7, July 2003.

15. Kubo, H; Gardner, T.A.; Wada, Y.; Koeneman, K.S.; Gotoh, A.; Yang, L.; Kao, C.; Lim S. D.; Amin, M. B.; Yang, H.; Black, M.E.; Matsubara, S.; Nakagawa, M.; Gillenwater, J.Y.; Zhau, H.E.; Chung, L.W.K.:  Phase I Dose Escalation Clinical Trial of Adenovirus Vector Carrying Osteocalcin Promoter-Driven Herpes Simplex Virus Thymidine Kinase in Localized and Metastatic Hormone-Refractory Prostate Cancer.  Human Gene Therapy, Volume 14 Number 3. 227-242, February 2003

16. Chen, Z.; Koeneman, K.S.; Corey, D.R.:  Consequences of Telomerase Inhibition and Combination Treatments for the Proliferation of Cancer Cells.  Cancer Research, 63 (18): 5917-25, September 15, 2003.

17. Johnson D.B., Taylor G.D., Lotan Y., Sagalowsky A.I., Koeneman K.S., Cadeddu J.A.:  The effects of radiofrequency ablation on renal function and blood pressure.  Journal of Urology, 170: 2234-6, 2003. 

18. Elmore, JA, Kadesky, K, Koeneman, KS, Sagalowsky, AI. Reassessment of the 1997 TMN Classification System for Renal Cell Carcinoma. Cancer, 98 (11): 2329-34, 2003.

19. Karam, Jose A., Mason, Ralph P., Koeneman, Kenneth S. Antich, Peter P., Benaim, Elie A.:  Molecular Imaging in Prostate Cancer. Journal of Cellular Biochemistry 90:473-483 (2003).

20. Khoddami, S., Shariatt, S., Saborian, H., Koeneman, K., Sagalowsky, A., Cadeddu, J., McConnell, J., Holmes, M., Roehrborn, C.:  Lympho-vascular Invasion as a Pathologic Feature in Biologically Aggressive Disease in Patients Treated with Radical Prostatectomy.  Journal of Urology, 171 (3):1122-7, March 2004.

21. Lotan, Y., Shariat, S., Khoddami, S., Koeneman, K., Cadeddu, J., Sagalowsky, A., McConnell, J., Roehrborn, C.:  The percent of biopsy cores positive for cancer is a predictor of advanced pathologic stage and poor clinical outcomes in patients treated with radical prostatectomy.  Journal of Urology, 171:2209-2214, June 2004.

22. Khoddami, S., Shariat, S., Lotan, Y., Saboorian, H., McConnell, Sagalowsky, A., Roehrborn, C., Koeneman, K.S.:  Predictive value of primary Gleason pattern 4 in Gleason score 7 patients treated with radical prostatectomy.  British Journal of Urology.  94:42-46, July 2004.

23. Sikes, R.A., Nicholson, B.E., Koeneman, K.S., Edlund, N.M., Bissonnette, E.A., Bradley, M.J., Thalmann, G.N., Cecchini, G., Pienta, K.J., Chung, L.:  Cellular Interactions in the Tropism of Prostate Cancer to Bone.  International Journal of Cancer, 110 (4): 497-503, July 2004.

24. Koeneman, K.S., Malaeb, B.S.: Better Living Through Innovation and Discovery: New Hope at University of Minnesota Center for Prostate Cancer. Masonic Cancer Center News. September 2004.

25. Taylor, G.D., Duchene, D.A., Koeneman, K.S.: Hand-assisted laparoscopic cystectomy with minilaparotomy ileal conduit: series report and comparison with open cystectomy. Journal of Urology.  172:1291-1296, Oct. 2004.

26. Sherwood, J.B., Taylor, G.D., Duchene, D.A., Broder, K.J., Koeneman, K.S.: Hand-assisted laparoscopic nephrectomy for large renal masses > 9.5 cm.: series report and comparison with open radical nephrectomy. Urologic Oncology, 23:323-327, Sept., 2005.

27. Malaeb, B.S., Martin, D.J., Littooy, F.N., Lotan, Y., Waters, W.B., Flanigan, R., Koeneman, K.S.: Utility of Screening Renal Ultrasonography: Identification of Renal Cell Carcinoma in an Elderly Asymptomatic Population. British Journal of Urology, 95:977-981, Dec. 2005.

28. Malaeb, B.S., Gardner, T.A., Margulis, V., Yang, L., Gillenwater, J.Y., Chung, L.W.K., Macik, G., Koeneman, K.S.: Elevated aPTT During Administration of First Generation Adenoviral Vectors for Gene Therapy of Prostate Cancer: Identification of Lupus Anticoagulants (LAC). Urology, 66(4), 830-844, Oct. 2005.

29. Canales, B.K., Li, Y., Thompson, M.G., Gleason, J.M., Chen, Z., Malaeb, B.S., Corey, D.R., Herbert, B.S., Shay, J.W., Koeneman, K.S.: Telomerase Inhibition in Combination with Cytolytic Therapy in an in-vitro Androgen Independent Prostate Cancer Model. Urologic Oncology, 24:141-151 (2006).

30. Malaeb, B.S., Rashid, H.H., Lotan, Y., Khoddami, S.M., Shariat, S.F., Sagalowsky, A.I., McConnell, J.D., Roehrborn, C.C., Koeneman, K.S.: Biochemical Recurrence Rates After Radical Retropubic Prostatectomies in Patients over 70 Years of Age. Urologic Oncology, in press.

31.  Cui, W., Otten, P., Li, Y., Koeneman, K.S., Yu, J., Mason, R.P.: Novel NMR Approach to Assessing Gene Transfection: 4-Fluoro-2-Nitrophenyl-β-D-Galactopyranoside as a Prototype Reporter Molecule for β-Galactosidase. Magnetic Resonance in Medicine, 51:616-620 (2004)

32. Yu, J., Ma, Z., Li, Y., Koeneman, K.S., Liu, L., Mason, R.P.: Synthesis and Evaluation of a Novel Gene Reporter Molecule: Detection of Beta-Galactosidase Activity Using 19F NMR of a Fluorinated Vitamin B6 Conjugate. Med Chem, 1:255-62 (2005)

33. Rashid, H.H, Koeneman, K.S.: Bladder Cancer: Toward State of the Art Multidisciplinary Molecular Medicine. Urologic Oncology, 24:322-3 (2006).

34. Rashid, H.H., Nelson, J., Koeneman, K.S.: Antiangiogenic and Cytotoxic Targeted Systemic Therapy for High Risk Prostate Cancer. Urologic Oncology, 24:243-245 (2006).

35. Koeneman, K.S.: Prostate Cancer Stem Cells, Telomerase Biology, Epigenetic Modifiers, and Molecular Systemic Therapy for the Androgen Independent Lethal Phenotype. Urologic Oncology, 24:119-121 (2006).

36. Rashid, H.H., Koeneman, K.S.: Prostate Cancer: Molecular Approaches for Detection and Prognosis and Angiogenic Therapeutic Targets. Urologic Oncology, 24:220-221 (2006).

37. Koeneman, K.S.: Strategies for Targeted Tumor Assessment and Elimination: The Physician-Scientist and the Blossoming of Molecular Medicine in Urologic Oncology. Urologic Oncology, 24:117-118 (2006)

38. Melquist, J.J., Kacka, M., Li, Y., Malaeb, B., Elmore, J., Baseman, A.G., Hsieh, J.T., Koeneman, K.S.: Conditionally Replicating Adenovirus-Mediated Gene Therapy in Bladder Cancer, an Orthotopic In Vivo Model, Urologic Oncology, 24:362-71 (2006).

39. Jones, M, Koeneman, KS. Does early androgen deprivation therapy improve outcome after radical prostatectomy? Nat Clin Pract Urol. 2007 Jan;4(1):20-1.

Top of page

BOOK CHAPTERS:

Bladder Cancer, in Pocket Medicine.com, Inc., Fall 2001 Edition, Philadelphia, PA. Updated Spring, 2006

“Bladder Sparing Approaches in Treatment of Muscle Invasive Bladder Cancer” in Urothelial Tumors,  B.C. Decker, Inc. Hamilton, ON, Canada, Chapter 16 (In press 4/02) Sagalowsky AI, Koeneman, KS

Top of page

ABSTRACTS (selected from over 50):

Li Y., Thompson M., Chen, Malaeb B., Corey D., Shay J., Koeneman K.: Telomerase Inhibition Prevents Androgen Independent Osseous Prostate Cancer Progression. AUA Annual Meeting, San Antonio, Texas, May 21-26, 2005, Abstract No. 463.

Spaulding J., Brekken R., Robinson L., Koeneman K., Mickey B., Cadeddu J., Croft C., Sagalowsky A., Ahmad N., Tomlinson G.E.: Serum Markers of Angiogenesis in Patients with von Hippel-Lindau Disease. ASCO Annual Meeting, New Orleans, Louisiana, June 5-8, 2004, Abstract No. 1033, Clinical Study.

Duchene D.A., Lotan Y., Cadeddu J.A., Sagalowsky A.I., Koeneman K.S.: Histopathology of Surgically Managed Renal Tumors:  Analysis of a Contemporary Series and Changing Treatment Options.  AUA 2003 Annual Meeting, Abstract #15, Chicago, IL. April 26, 2003, moderated Poster.

Lotan Y., Duchene D.A., Koeneman K.S., Cadeddu J.A.:  Cost Comparison of Standard Laparoscopic and Hand-Assisted Laparoscopic Radical Nephrectomy.  AUA 2003 Annual Meeting, Abstract #15, Chicago, IL. April 26, 2003, moderated Poster.

Elmore, JM., Kadesky, KT., Koeneman, KS., Sagalowsky, AI.:  Reassessing the 1997 Classification System for Renal Cell Carcinoma:  A 5.0 CM T1/T2 Cut-Off Better Stratifies Clinical Outcome.  AUA 2002 Annual Meeting, Orlando, FL, 05/27/02.

Baseman, AG., Wilhelm, DM., Elmore, JM., Kacka, M., Li Y., Koeneman, KS.:  Intravenous Bone Sialoprotein Promotoer-Based Replication Competent Adenovirus Treatment of Bone Metastatic Prostate Cancer.  AUA 2002 Annual Meeting, Orlando, FL, 05/27/02.

Li Y., Wilhelm D., Kacka M., Baseman AG., Elmore, J., Shay J., Koeneman, KS.:  Selective Systemic Telomerase Inhibition in Combination with Cytolytic Therapy Cures Osseous Prostate Cancer.  AUA 2002 Annual Meeting, Orlando, FL, 05/28/02.

Baseman AG., Wilhelm D., Kacka M., Li Y., Koeneman KS.:  Bone Sialoprotein Promoter-Driven Conditionally Replication Competent Toxic Adenoviral Treatment of InVitro and In Vivo Bladder Cancer: Correlation Vector to CAR Expression.  AUA 2002 Annual Meeting, Orlando, FL, 05/27/02.

Li Y., Wilhelm D., Kacka M., Baseman AG., Elmore, J., Shay J., Koeneman, KS.:  Systemic Telomerase Inhibition in Combination with Ad Virus and Taxol Cures Osseous CaP.  AACR Florida Prostate Cancer Meeting, 12/08/01. 

Koeneman, KS, Gardner, TA, Chung, LWK, Macik,  GB: Mechanism of Elevated aPTT during Administration of Adenoviral Vectors for Gene Therapy. American Society of Gene Therapy (ASGT)  3rd Annual Meeting, Denver, CO, June 1-4, 2000.

Li , S, Koeneman, KS, Chung, LWK, Schally, AV, Nagy, A. Prostate Tumor Receptor Targeted Therapy by Intravenous Somatostatin Conjugated Doxorubicin(AN-238). AUA 95th Annual Meeting , Abstract #4420, Atlanta, Georgia, 05/02/00 ( moderated poster).

Koeneman, KS, Sikes , RA,  Yeung ,F, Hsieh, C, Chung, LWK, Sodek, J. Adenovirus Mediated Gene Therapy Can Target Metastatic Prostate cancer by Using the Bone Sialoprotein (BSP) Promoter. AUA 95th Annual Meeting, Abstract #907, Atlanta, GA, 04/02/00, (moderated poster).

Koeneman, KS, Yeung, F, Hsieh, C., Sikes, RA, Kao, C, Chung, LWK: Gene Therapy Approach to Human Prostate Cancer Metastasis: the “Community Effect”.  CaP CURE 6th Annual Scientific Retreat, Lake Tahoe, Nevada, 10/15/99 ( poster).

Koeneman, K.S., Yeung, F., Sikes, R.A., Chung, L.W.F., Nelson, J.B.: Transcriptional downregulation of PSA, and enhanced growth of prostate cancer (CaP) cells by co-culture with osteoblastic cells.  AUA 94th Annual Meeting, Abstract #369, Dallas Texas, 05/02/98 (moderated poster).

Nicholson, B.E., Koeneman, K.S., Flanigan, R.C.: Phase II Clinical Trial of Low Dose Alphinterferon in Patients with Advanced Hormone Refractory Prostate Cancer.  North Central Section of AUA Annual Meeting, Amelia Island, Florida, October 1998.  (poster/podium presentation)

Koeneman, K.S., Nicholson, B.E., Wilhelm, D., Flanigan, R.C., Waters, W.B.: Clinical Utility of Radioimmunoscintigraphy (Prostascint) in Prostate Cancer.  North Central Section of AUA Annual Meeting, Amelia Island, Florida, October 1998. (podium presentation)

Koeneman, K.S., Pan, C-X, Diaz, M.O., Mulhall, J.P.:Telomerase Activity in Testis Biopsy of Infertile Men. AUA 93rd Annual Meeting, San Diego,06/02/98 (poster presentation).

Koeneman, K.S., Pan,C-X, Jin ,J-K, Pyle,J.M., Flanigan,R.C., Diaz,M.O., Shankey, T.V.: Telomerase Activity, Telomere Lenght, and DNA Ploidy In PIN. American Association of Cancer Research (AACR), Annual Meeting, New Orleans, 04/01/98 (moderated poster presentation).

Koeneman, K.S., Pan, C-X.,Jin, J-K., Pyle, J.M., Flanigan, R.C., Shankey, T.V., Diaz, M.O.: Telomerase and Ploidy in PIN (prostatic intraepithelial neoplasia).  North Central Section AUA, Monterey, CA., September 1997 (poster/podium presentation).

Koeneman, K.S., Cote, W.L., Martin, D.J., Littooy, F.N., Flanigan, R.C.:  Renal Screening Ultrasound in an Older Population with Pathologic Correlation.  J. of Urol., 157, no. 4, abstract 1276, AUA  92nd Annual Meeting, New Orleans, April 1997 (podium presentation).

Koeneman, K.S., Flom, L.S., Pielet, B.:  Unusual Case of Obstructing Ureterocele-Producing Oligohydramnios and Renal Insufficiency.  North Central Section of AUA Annual Meeting, Tucson, Arizona, October 1996 (podium presentation).

Top of page

LECTURES:

Invited Lectures, Peer Reviewed

Chicago Urologic Society, Annual Irving J. Shapiro X-Ray Conference

• “Pediatric Infravesical Obstruction,” April 1996
• “Obstructing Ureterocele in a Fetus,” April 1997

Chicago Urology Resident Debate, May 1997

• “Con Argument-Neoadjuvant Therapy Prior to Radical Prostatectomy”

Chicago Urologic Huggins Essay Contest, January 1998

• “Telomerase Activity and DNA Ploidy in High Grade PIN”
• “Phase II Clinical Trial of Low Dose, Subcutaneous Daily Alpha- Interferon in Advanced Hormone Resistant Prostate Cancer” 

Chicago Urological Society Program on Bladder Cancer,  March 4, 1998

• “Bladder Cancer: Epidemiology, Risk Factors and Molecular Etiology”

“Current Status of Gene Therapy for Prostate Cancer”
Texas Urological Society, Jackson Hole, WY, 06/21/01

“Prostate Cancer Gene Therapy:  Update on Trials and Future Directions”
Society of Urologic Oncology, AUA Annual Meeting, Annaheim, CA, 06/02/01

“CaP and PSA Screening:  a critical evaluation”
Dallas Internists Club, 09/13/01

“Prostate Cancer Diagnosis:  pearls and pitfalls”
Parkland Health System, Community Oriented Primary Care, 12/06/01

“Current Directions of Bladder Cancer Therapy" and
“Rising PSA after RRP: Current Role of Molecular Therapies”
UTSW Annual Paul C. Peters Urologic Lectureship, Jan 25-26, 2002

“Hereditary and Familial Prostate Cancer, Patrick Walsh M.D.
“Surgical Radical Prostatectomy”, Breakout Session: Patrick Walsh, M.D.,

“Treatment of Hormone Refractory Prostate Cancer, new Trials”

“Hormone Refractory Prostate Cancer"
UTSW Annual Paul C. Peters Urologic Lectureship, January 24-25, 2003.

“Prostate Cancer:  Diagnosis and Treatment”
SUNA (Society of Urologic Nursing Association), February 22, 2003.

“BSP promoter Driven Adenovirus gene therapy for Prostate Cancer”
“Laparoscopic Cystectomy: Technique and Series Report and Comparison to Open Surgery”.  University of British Columbia Visiting Professor in Urology, August 28 to 31, 2003.

“Case Studies on High Grade Prostate Cancer: Multimodality treatment and   Future Biologies”,  International Urology Network, Austin, TX, 09/23/03.

“Adenovirus based Gene Therapy for Osseous Prostate Metastasis”
University of Minnesota Cancer Center, Minneapolis, MN, 09/26/003.

“PSA and Prostate Cancer: Critical Concerns”
30th Annual Family Practice Update Course, University of Minnesota, Minneapolis, MN, 05/05/04.

“Prostate Cancer Symposium”
Course Director, University of Minnesota, Minneapolis, MN, 09/23/04.

“Laparoscopic Radical Prostatectomy; Reporting on Radical Prostatectomy Specimens”
Department of Pathology Grand Rounds, University of Minnesota, Minneapolis,  MN, 01/12/05.

“Advances in the Care of Prostate Cancer Patients”
Fairview Lakes Medical Center Grand Rounds, Wyoming, MN, 02/04/05.

“Advances in the Care of Advanced Prostate Cancer and Bone Metastasis”
Metro Minnesota Oncology Nursing Society Meeting, Minneapolis, MN, 06/14/05.

”Kidney/Ureter Benign/Adrenal Podium” Session discussant
American Urological Society North Central Section Annual Meeting, Chicago, IL, 09/09/05.

“The 3 P’s of BPH: Progression, PSA, Pharmacotherapy”
Men’s Health Night, Minneapolis, MN, 09/15/05.

“Medical Treatment of BPH Symptoms”, SUNA, Society of Urological Nursing
Minneapolis, MN, October 25 and 27, 2005

“Prostate Cancer, Prostatectomy, Endocrine Therapy, and Quality of Life Issues”
GU Department Core Curriculum, 11/30/05

Johns Hopkins Prostate Cancer Research Day, Consultant, 02/10/06

“Treatment Options for Prostate Cancer”
Urology for Primary Care, Minneapolis, MN, 03/03/06

“Advanced Prostate Cancer Treatment Options”
Society of Urologic Nursing Association, Chicago, IL, 04/26/06

“Multidisciplinary Care of Prostate Cancer”
U of MN Department of Family Medicine Faculty Grand Rounds, Minneapolis, MN, 05/17/06

Moderator, Prostate Cancer Basic Research Poster Session, AUA Annual Meeting, 05/21/06

“What is Locally Advanced Disease?” and  “What is Locally Advanced Disease and How Should it Be Treated?”, Panel Member, SUO Annual Meeting, 12/01/06

Top of page

Community Service / Public Mass Media

WNPR- Public Radio Broadcast, "With Good Reason” 103.5 FM, 1/30/2000, “Prostate Cancer Gene Therapy: Novel Approaches in the Clinic and in the Lab”

Primedia HealthCare, “Work Place Learning”, CME Course for physicians
“PSA and Prostate Cancer: Critical Concerns”, 9/2002

UPI Science News: Editorial for United Press International on news release, “Hormone Therapy works for Prostate Cancer”, 7/11/2002. 

AARP Bulletin, June 2002: “Taming Cancers Big 4 Killers, Prostate Cancer Surgery and Radiation”, Washington, D.C.

Clinical Update, December 2002, Zale Lipshy University Hospital UTSW.
“Laparoscopic surgery simplifies recovery process”

WCCO Radio, 11/21/04: “Fairview On Call” with Maria Dahl, MD, and Denny Long: “Prostate Cancer and PSA”

WCCO Radio, 07/17/05: “Fairview On Call” with Maria Dahl, MD: “Novel Treatments for Prostate Cancer”

University of Minnesota Dean’s Report, Spring 2005: “Fighting Prostate Cancer”

Top of page

Community Support Lectures

American Cancer Society (ACS) Prostate Cancer Support Group:
“Man to Man” and “Prostate Cancer Bone Metastasis, Etiology and Treatment”
Waynesboro, VA, 01/21/99

“Prostate Metastasis, Molecular Basis and Novel Therapies”
Lynchburg, VA, 04/20/99

"Novel Gene Therapy for Prostate Cancer Bone Metastasis: Phase I Clinical Trial Results”, Waynesboro, VA, 09/16/99

“Prostate Cancer Screening”, University of Minnesota Comprehensive Cancer Center, “Cancer U” Educational Day, Minneapolis, MN, 04/14/04

“Prostate Cancer Treatment: Past, Present, Future”, University of Minnesota Comprehensive Cancer Center, “Cancer U, Men and Cancer” Educational Program, Minneapolis, MN, 11/11/04

“Prostate Cancer Multidisciplinary Clinic Update”, Minnesota Men’s Breakfast, Naples, FL, 03/04/05

"Prostate Cancer Multidisciplinary Clinic Update”, Minnesota Medical Foundation Receptions, March 3 & 4, 2005, Sanibel Island and Naples, FL

“Impact of Prostate Cancer on Men’s Health and the Community”
Daybreakers Minnesota Men’s Breakfast Club, Minneapolis, MN, 06/22/05

“Prostate Cancer Early Detection”, June 25, 2005, Emmanuel Tabernacle Church of God in Christ “Celebrate Life! A Community Healthfare Fundraiser Breakfast”, Minneapolis, MN.

“PSA Screening”, Church Olympics & Family Day/Health Fair, Minneapolis, MN, 06/25/05

“Prostate Cancer and African American Men”
Christ Temple Church, Brooklyn Center, MN, 07/17/05

"Hormonal Therapy for Prostate Cancer”, Morton’s Steakhouse, 07/28/05

“PSA Screening”, PACE Race, Minneapolis, MN, 07/30/05

“Erectile Function and Prostate Cancer: Current Effective Treatments”, Mercy Hospital Prostate Cancer Support Group, Maplewood, MN, 08/23/05

“Telomerase Inhibitors and Osseous Prostate Cancer,” Cancer Center Seminar Series, November 22, 2005, Minneapolis, MN

“University of Minnesota Center for Prostate Cancer, and Novel Paradigm for Aggressive Prostate Cancer Treatment” Cancer Center Community Advisory Board Meeting, December 1, 2005, Minneapolis, MN

“Sexual Rehabilitation after Prostate Cancer Therapy” Community Lecture: Nurses and Physicians, December 5, 2005, Minneapolis, MN

“Prostate Cancer Update: Hormonal to Chemotherapy for Advanced Disease” Community Lecture: Nurses, Physicians, and Pharmacists, 12/08/05, Minneapolis, MN

“Prostate Cancer: Diagnosis and Care” Edina Rotary Club, 12/08/05

“Effective Integration of Prostate Cancer Multidisciplinary Clinic”
Center for Prostate Cancer Advisory Board Meeting, 12/16/05, Minneapolis, MN

“Prostate Cancer” Apple Valley Rotary Club Talk, 02/08/06

“Prostate Cancer Update: LHRH to Chemotherapy” Community Lecture: Urology Nurses, Oncology Nurses and Oncology Pharmacists, 02/09/06, Edina, MN

“Prostate Cancer Treatment and Multidisciplinary Care”
Golden Valley Country Club, Breakfast Club Business Group, 03/01/06

“Advances in Urologic Prostate Surgery:  Laparoscopic Robotic Prostatectomy” Minneapolis Club, Fairview Foundation Group, 09/21/06

“Advances in Urologic Prostate Surgery:  Laparoscopic Robotic Prostatectomy”
CaP Lecture, Maple Grove Community Center, 09/28/06

“Advances in Urologic Prostate Surgery: Laparoscopic Robotic Prostatectomy” Cancer Center –University of Minnesota, 09/30/06

Dallas Area Community Prostate Cancer Support/Awareness Program:
“Men’s Health: PSA Screening and Prostate Cancer”, Dallas – Fort Worth Metroplex

1) TDI Industries, November 2000
2) Nieman Marcus, January 2001
3) Belo Corp., February 2001
4) Palm Harbor Holmes, 06/06/01
5) Hunt Oil Corp., 06/28/01
6) TXU (Texas Utilities), 01/15/02
7) Nieman Marcus (Corporate Headquarters), 01/23/02
8) Hunt Oil Corp., 07/20/02

Top of page